(Q39641473)

13 September 2017

1 reference

title

L-tryptophan: a rational anti-depressant and a natural hypnotic? (English)

1 reference

13 September 2017

0 references

B Boman

1

1 reference

13 September 2017

publication date

1 March 1988

1 reference

Australian and New Zealand Journal of Psychiatry

13 September 2017

published in

1 reference

13 September 2017

volume

22

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

83-97

1 reference

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Control of brain tryptophan concentration in rats on a high fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. II. Applications and drug studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

21 January 2018

The new biology of sleep

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Morphological and Functional Aspects of Central Monoamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Antidepressant effects of light in seasonal affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

5-Hydroxyindoleacetic Acid Levels in the Cerebrospinal Fluid of Depressive Patients treated with Probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

5-Hydroxytryptamine in the Hind-Brain of Depressive Suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

5-hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Total and free tryptophan concentration in the plasma of depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Monoamine oxidase inhibitors. A review of antidepressant effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Novel Antidepressants and the Biogenic Amine Hypothesis of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Mechanism of the antidepressant action of electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

The effect of L-dopa on the concentrations of tryptophan, tyrosine and serotonin in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

The psychiatric complications of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Relationships between stress and brain 5-hydroxytryptamine and their possible significance in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Tryptophan Pyrrolase—A Biochemical Factor in Depressive Illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Tryptophan metabolism in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Tryptophan in the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Letter: Treatment of unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Tryptophan-nicotinamide, imipramine and their combination in depression. A controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Letter: Tryptophan/imipramine in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Plasma tryptophan tolerance curves in drug free normal controls, schizophrenic patients and prisoner volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Normalization of brain serotonin by L-tryptophan in levodopa-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Mental symptoms in Parkinson's disease during chronic treatment with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Potentiation of a monoamine oxidase inhibitor by tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Potentiation of the antidepressant action of clomipramine by tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Potentiation of lithium by tryptophan in a patient with bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Affective disorder: studies with amine precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Addition of L-tryptophan to electroconvulsive treatment in endogenous depression. A double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Evaluation of the combination of tryptophan and ECT in the treatment of depression. I. Clinical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Effect of L-Tryptophan on Brain Serotonin Metabolism in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

A Controlled Trial of L-Tryptophan in Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Biogenic amines and the states of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

The effect of para-chlorophenylalanine on the sleep of cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

The effect of some psychoactive drugs on central monoamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Effects of L-tryptophan (a natural sedative) on human sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Some experiments in the chemistry of normal sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Tryptophan and sleep in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

L-Tryptophan + Oxprenolol: A New Approach to the Treatment of Insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Comparative study of tumorigenicity in mice administered transplacentally or neonatally with metabolites of tryptophan and its related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

The metabolism of tryptophan. 2. The metabolism of tryptophan in patients suffering from cancer of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Scleroderma-like lesions and the carcinoid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Induction of Pulmonary Edema and Emphysema in Cattle and Goats with 3-Methylindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Effects of 3-methylindole in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Enhancement of the Antidepressant Response to <i>L</i>-Tryptophan by a Liver Pyrrolase Inhibitor: a Rational Treatment Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

Case report of a toxic reaction from a combination of tryptophan and phenelzine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00048678809158946

10.1080/00048678809158946

21 January 2018

Identifiers

DOI

1 reference

release_6lqhigcdhvgqzbvslrlqtxdgom

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6lqhigcdhvgqzbvslrlqtxdgom

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference